Evidence map›Paper›PMID 36771263›Full record

ArticleNutrients2023

Triglyceride-Glucose Index as a Potential Indicator of Sarcopenic Obesity in Older People.

Bokun Kim, Gwonmin Kim, Yongkook Lee, Keisuke Taniguchi, Tomonori Isobe, Sechang Oh

Abstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sarcopenic Obesity Phenotype Index (SOPi): A Population-Based Study.Journal of cachexia, sarcopenia and muscle · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bokun KimDepartment of Anti-Ageing Health Care, Changwon National University, Changwon 51140, Republic of Korea.ORCID 0000-0001-9553-3368
Gwonmin KimMedical Research Institute, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0001-7901-3506
Yongkook LeeDepartment of Leisure Sports, Seoil University, Seoul 02192, Republic of Korea.
Keisuke TaniguchiDepartment of Physical Therapy, AHRU Medical Care and Welfare Professional Training College, Tsuchiura 300-0032, Japan.
Tomonori IsobeFaculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Sechang OhFaculty of Rehabilitation, R Professional University of Rehabilitation, Tsuchiura 300-0032, Japan.

Funding

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan 22H03527National Research Foundation of Korea grant, funded by the Ministry of Education NRF-2022R1l1A1A01063664
6 · The paper itself

Abstract

purposeThis population-based cross-sectional study aimed to determine whether the triglyceride-glucose index (TyG index) is associated with sarcopenic obesity (SO) and whether it would be a helpful indicator of SO.

methodsA total of 3821 participants aged ≥ 60 years were selected for the study group, and 4919 participants aged 20-39 years were included as a reference group. The participants were allocated to sarcopenia, obesity, and SO groups depending on if their body mass index (BMI) was ≥25 kg/m

resultsAs the TyG index increased, BMI increased, but the sarcopenia index decreased in both sexes. Males and females in the middle and highest tertiles of the TyG index were 1.775 and 3.369, and they were 1.993 and 3.157 times more likely to have SO, respectively. The cut-off values of the TyG index for SO in males and females were ≥8.72 and 8.67, respectively.

conclusionA high TyG index is positively associated with SO, and the TyG index may be considered a potential indicator of SO.

Indexed as

Insulin ResistanceSarcopeniaAgedBiomarkersBlood GlucoseCross-Sectional StudiesFemaleGlucoseHumansMaleObesityRisk FactorsTriglyceridesBiomarkersBlood GlucoseGlucoseTriglyceridesinsulin resistanceobesityolder populationsarcopeniasarcopenic obesityTyG index

Identifiers

PMID36771263
PMCPMC9920571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.